- Raised $1M grant, Oct 2015
- Raised funding round, Sep 2016
About
Curewize Health is a clinical research and commercialization company aiming to advance the personalized treatment of cancers common to children, adolescents, and young adults. The company's lead product family is ProALL, microRNA-based predictive tests for early diagnosis and monitoring of acute lymphoblastic leukemia patients. Curewize's systematic approach is focused on commercializing clinically validated biomarkers to ensure fast market entry. Curewize is also performing R&D for the development of a precision lab test for certain therapies. Altered miRNA patterns can be used to decide on treatment with specific therapies. The company's companion diagnostic test can enable personalized medicine for diverse cancer patients. In addition, the Curewize platform technology is suitable for the development of a diverse portfolio of microRNA lab tests for personalized medicine, diagnosis, and prognosis of numerous diseases. The company is also developing ProState blood tests for the detection of high-accuracy prostate cancer patients. ProState aims to help prevent the over-treatment of prostate cancer patients with radical prostatectomy surgery or radiotherapy.
Funding history · 2 rounds · $1.0M total
Q&A
- What is Curewize Health's primary focus?
- Curewize Health is a clinical research and commercialization company focused on advancing personalized treatment for cancers common in children, adolescents, and young adults. Their lead product family, ProALL, consists of microRNA-based predictive tests for acute lymphoblastic leukemia.
- When was Curewize Health founded?
- Curewize Health was founded in February 2013.
- What is the current status of Curewize Health?
- Curewize Health is currently inactive, having ceased operations in October 2022.
- How much funding has Curewize Health raised in total?
- Curewize Health has raised a total of $1,000,000.
- Which investors participated in Curewize Health's Grant round?
- In October 2015, Curewize Health received a Grant round with participation from.
- What is Curewize Health's employee count?
- Curewize Health has 1-10 employees.
- What is Curewize Health's lead product family?
- Curewize Health's lead product family is ProALL, which includes microRNA-based predictive tests for the early diagnosis and monitoring of acute lymphoblastic leukemia patients.
- What other diagnostic tests is Curewize Health developing?
- Curewize Health is also developing ProState blood tests for the high-accuracy detection of prostate cancer patients, aiming to prevent overtreatment.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | curewize.com/ |
|---|---|
| linkedin.com/company/3328040 | |
| facebook.com/Curewize | |
| YouTube | youtube.com/user/Curewize |
Identifiers & details
| Founded | 2013-2 |
|---|---|
| Employees (exact) | 1 |
| Status reason | Non Active, Oct 2022 ceased to operate |